- Home
- OBIO vs FHTX Comparison
OBIO vs FHTX Comparison
Compare OBIO & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- FHTX
- Stock Information
- Founded
- OBIO 2017
- FHTX 2015
- Country
- OBIO United States
- FHTX United States
- Employees
- OBIO N/A
- FHTX N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- FHTX Medicinal Chemicals and Botanical Products
- Sector
- OBIO Health Care
- FHTX Health Care
- Exchange
- OBIO Nasdaq
- FHTX Nasdaq
- Market Cap
- OBIO 118.8M
- FHTX N/A
- IPO Year
- OBIO N/A
- FHTX 2020
- Fundamental
- Price
- OBIO $2.76
- FHTX $4.89
- Analyst Decision
- OBIO Strong Buy
- FHTX Strong Buy
- Analyst Count
- OBIO 5
- FHTX 8
- Target Price
- OBIO $14.20
- FHTX $12.63
- AVG Volume (30 Days)
- OBIO 400.2K
- FHTX 141.1K
- Earning Date
- OBIO 08-11-2025
- FHTX 08-07-2025
- Dividend Yield
- OBIO N/A
- FHTX N/A
- EPS Growth
- OBIO N/A
- FHTX N/A
- EPS
- OBIO N/A
- FHTX N/A
- Revenue
- OBIO $2,886,000.00
- FHTX $23,504,000.00
- Revenue This Year
- OBIO $20.47
- FHTX $44.01
- Revenue Next Year
- OBIO $11.45
- FHTX $9.45
- P/E Ratio
- OBIO N/A
- FHTX N/A
- Revenue Growth
- OBIO 30.23
- FHTX N/A
- 52 Week Low
- OBIO $2.37
- FHTX $2.95
- 52 Week High
- OBIO $8.87
- FHTX $10.25
- Technical
- Relative Strength Index (RSI)
- OBIO 46.73
- FHTX 61.01
- Support Level
- OBIO $2.96
- FHTX $4.65
- Resistance Level
- OBIO $3.48
- FHTX $5.09
- Average True Range (ATR)
- OBIO 0.24
- FHTX 0.32
- MACD
- OBIO -0.02
- FHTX 0.03
- Stochastic Oscillator
- OBIO 11.76
- FHTX 72.94
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.